MedPath

MOVING - MOtiVation, INtervention and Vascular chanGe

Not Applicable
Completed
Conditions
Endothelial Function (Reactive Hyperemia)
Interventions
Behavioral: health-behavior seminar and endurance exercise
Registration Number
NCT01919632
Lead Sponsor
Technical University of Munich
Brief Summary

Background: The impact of demographic changes on workplace has increased the importance of effective occupational preventive health programs. The primary goal of these programs is the improvement of overall health status (and therefore increase productivity and decrease healthcare costs) of the increasingly older workforce through positive lifestyle behavior change.

A one- year preventive health behavior-change program for the employees of the company British Petrol (BP) shall be scientifically evaluated. The initial stage of the program consists of a health-behavior seminar and six weeks (twice a week for 90 minutes) of supervised endurance exercise (i.e. jogging, nordic walking, cycling or swimming) in groups. In the second phase of the program, the participants receive a recommendation to continue exercise regularly unsupervised for one year, and receive monthly supervised exercise training sessions. Clinical check-ups are performed at baseline (V1) at three months (V2) and at 12 months (V3).

Detailed Description

The study will investigate the effect of one year of participation in a lifestyle- intervention- program on the participants' metabolic risk profile, exercise capacity and vascular health. A primary focus is on the endothelium, because poor endothelial health is a risk factor and prognostic indicator of atherosclerosis and cardiovascular events.

Hypothesis: One year of participation in endurance exercise (twice a week for 90 minutes) may positively influence endothelial health (RHI)

The primary aim:

change in endothelial function (reactive hyperemia index (RHI)) after one year.

Secondary aims:

Changes in other vascular parameters (AI: augmentation index, CAVI: Cardio ankle vascular index, ABI: ankle brachial index ), changes in anthropometric, inflammatory and metabolic parameters, exercise capacity (Watt/kg), physical activity, and health related quality of life (HRQoL).

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
330
Inclusion Criteria
  • Employees of the company British Petrol (BP) in Lingen, Germany
  • men and woman of all age
  • approval for being able to participate in physical activity
  • existing, written agreement to study-participation with prior, detailed education
Exclusion Criteria
  • Acute or chronic disease of any kind, which does not allow participation in physical activity (missing approval of being able to participate in physical activity)
  • Incompetent patient, who is not able to understand character, meaning and consequences of the study

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Lifestylehealth-behavior seminar and endurance exerciseThe initial stage of the program consists of a health-behavior seminar and six weeks (twice a week for 90 minutes) of supervised endurance exercise (i.e. (?) jogging, nordic walking, cycling or swimming) in groups. In the second phase of the program, the participants receive a recommendation to continue exercise regularly unsupervised for one year, and receive monthly supervised exercise training sessions.
Primary Outcome Measures
NameTimeMethod
Change in RHI (Reactive Hyperemia Index)after 0 months (V1), 3 months (V2), 12 months (V3)

endothelial function

Secondary Outcome Measures
NameTimeMethod
Health related quality of life (HRQoL)after 0 month (V1) and 12 month (V3)

questionnaire

Exercise capacity (Watt/kg)after 0 month (V1) and after 12 month (V3)

Changes from baseline in exercise capacity (Watt/kg) at 12 month

CAVI (Cardio ankle vascular index)after 0 months (V1), 3 months (V2), 12 months (V3)

Vascular function: Change from baseline in CAVI (Cardio ankle vascular index) at 12 month

Anthropometric parameters (see description)after 0 months (V1), 3 months (V2), 12 months (V3)

Changes from Baseline in systolic/diastolic blood pressure, weight, body-fat and waist-circumference at 12 month

Inflammatory and metabolic parameters from blood samples (see description)after 0 month (V1), 3 month (V2), 12 month (V3)

Change from baseline in blood glucose, HbA1c, total cholesterol, HDL, LDL, triglycerides (metabolic parameters) and C-reactive protein (inflammatory parameters)at 12 month

AI (Augmentation Index)after 0 month, 3 month, 12 month

Vascular function: Change from baseline in AI (Augmentation Index) at 12 month

ABI (Ankle-Brachial-Index)after 0 month, 3 month, 12 month

Vascular function: Change from baseline in ABI (Ankle-Brachial-Index)at 12 month

Trial Locations

Locations (2)

BP Lingen

🇩🇪

Lingen, Emsland, Germany

Klinikum rechts der Isar, Technische Universität München

🇩🇪

Munich, Bavaria, Germany

© Copyright 2025. All Rights Reserved by MedPath